Halbert Hargrove Global Advisors’s Regeneron Pharmaceuticals REGN Stock Holding History

Halbert Hargrove Global Advisors’s Portfolio REGN Stock Details REGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$524	Buy	+1	New	+$681	﹤0.01%	523
2025 Q4	–	Sell	-4	Closed	-$2.25K	–	668
2025 Q3	$2.25K	Buy	+4	New	+$2.26K	﹤0.01%	542
2025 Q2	–	Sell	-4	Closed	-$2.54K	–	579
2025 Q1	$2.54K	Buy	+4	New	+$2.75K	﹤0.01%	378
2015 Q3	–	Sell	-628	Closed	-$320K	–	152
2015 Q2	$320K	Sell	628 -348	-36%	-$170K	0.08%	129
2015 Q1	$441K	Buy	976 +370	+61%	+$157K	0.14%	105
2014 Q4	$249K	Sell	606 -12	-2%	-$4.72K	0.12%	111
2014 Q3	$223K	Sell	618 -241	-28%	-$80.8K	0.06%	131
2014 Q2	$243K	Buy	859 +92	+12%	+$27.3K	0.07%	102
2014 Q1	$230K	Buy	+767	New	+$236K	0.07%	106

Other funds holding REGN

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

MCI

McDonald Capital Investors Orinda, California $1.37B AUM 1.88% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return

Retirement Systems of Alabama Montgomery, Alabama $33.2B AUM 38.15% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

Parnassus Investments San Francisco, California $37.4B AUM 35.42% 1-Year Est. Return

Halbert Hargrove Global Advisors's REGN Position: Q2 2026 in Review

Halbert Hargrove Global Advisors opened a new position in Regeneron Pharmaceuticals (REGN) in Q2 2026: 1 share worth $524. The stake represents ﹤0.01% of the portfolio and ranks #523 among its holdings. This is a return to the name: Halbert Hargrove Global Advisors previously reported a position in REGN as recently as Q3 2025.

Halbert Hargrove Global Advisors first reported a position in REGN in Q1 2014 and has held it in 9 quarters since. The position peaked at $441K in Q1 2015. 518 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

Halbert Hargrove Global Advisors held 1 share of Regeneron Pharmaceuticals worth $524 as of Q2 2026.
Regeneron Pharmaceuticals was a new Halbert Hargrove Global Advisors position in Q2 2026.
Regeneron Pharmaceuticals made up ﹤0.01% of Halbert Hargrove Global Advisors's portfolio in Q2 2026, its #523 holding.
Halbert Hargrove Global Advisors first reported a position in Regeneron Pharmaceuticals in Q1 2014 and has held it in 9 quarters since.
Halbert Hargrove Global Advisors's Regeneron Pharmaceuticals position peaked at $441K in Q1 2015.
518 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Halbert Hargrove Global Advisors's 13F filing for Q2 2026, filed 21 Jul 2026.